Clinical Trial

The GORE® VIABAHN® FORTEGRA Venous Stent Post-Approval Study

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study is a prospective, multicenter, single-arm post-market clinical study to evaluate the GORE® VIABAHN® FORTEGRA Venous Stent in real-world use.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-04-13; most recent amendment 2026-05-11.
Trial Details
NCT Number NCT07538609
Lead Sponsor W.L.Gore & Associates
Conditions Venous Thromboses, Venous Disease, Venous Leg Ulcer, Venous Stasis, Venous Ulcer, Venous Stenosis, Venous Occlusion, Vein Thrombosis
Enrollment 150 participants
Start Date 2026-10-07
Primary Completion 2029-05 (estimated)
Study Completion 2031-05 (estimated)
Updated on ClinicalTrials.gov 2026-08-12